LiT, UMR CNRS 7200                

We explore several therapeutic fields (pain modulation, inflammatory diseases, cancer or rare diseases, etc) through the establishment of national or international scientific networks involving molecular biologists, pharmacologists, etc. Our aim is to characterize the newly synthesized molecules through both in vitro and in vivo biological models.